+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Rapid Diagnostic Kits Market for Indian Ocean Region Countries by Product, Platform, Application, End User - Forecast to 2029

  • PDF Icon

    Report

  • 145 Pages
  • January 2023
  • Region: India
  • Meticulous Market Research Pvt. Ltd.
  • ID: 5715967
Rapid Diagnostic Kits Market for Indian Ocean Region Countries by Product (Professional, OTC), Platform (Immunoassay, Molecular), Application (Infectious Diseases, Cardiac, Urinalysis, Cholesterol), End User (Hospitals, Diagnostic Labs) - Forecast to 2029

The rapid diagnostics kits market for Indian Ocean region countries is expected to grow at a CAGR of 1.6% from 2022 to 2029 to reach $1.75 billion by 2029.

Following thorough secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities.

The growing demand for PoC diagnostics, the high prevalence of chronic diseases coupled with the increasing geriatric population, the growing prevalence of infectious diseases, the increasing need for rapid decision-making, and the outbreak of the COVID-19 pandemic are the key factors driving growth in the market. However, variance in test results is a restraining factor for the growth of this market. Additionally, the reluctance to change the existing diagnostic practices is a major challenge for market growth.

Based on product, in 2022, the professional kits segment is expected to account for the larger share of the rapid diagnostic kits market in Indian Ocean region countries. The large market share of this segment is attributed to increasing hospitalizations, the high prevalence of chronic diseases such as cancer and cardiac conditions, the advantages of rapid diagnostic kits over laboratory tests, including low cost and low turnaround time, and their gradual increase in the use.

Based on platform, in 2022, the immunoassays segment is expected to account for the largest share of the rapid diagnostic kits market in Indian Ocean region countries. The large market share of this segment is mainly attributed to the high prevalence of chronic and infectious diseases, technological innovations, and the advantages of rapid immunoassay tests, such as cost-effectiveness and at-home testing.

Based on application, in 2022, the infectious diseases testing segment is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries. The high prevalence and outbreaks of infectious diseases and the high adoption of self-testing kits for infectious diseases are primary factors supporting the large market share of this segment.

Based on end user, in 2022, the hospitals & clinics segment is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries. Factors attributing to this segment's growth include increasing hospitalizations due to various diseases, the increasing geriatric population, and increased healthcare access & expenditure.

An in-depth analysis of the geographical scenario of the rapid diagnostic kits market for Indian Ocean region countries provides detailed qualitative and quantitative insights about the major geographies (France, India, Australia, Singapore, Indonesia, Madagascar, Mauritius, Réunion, Comoros, Mayotte, and Seychelles). France is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries in 2022, followed by India, Australia, Indonesia, and Singapore.

Key companies operating in the rapid diagnostic kits market for Indian Ocean region countries are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).

Scope of the Report

Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Product

  • Professional Kits
  • OTC Kits

Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Platform

  • Immunoassays
  • Molecular Detection
  • Other Rapid Diagnostic Platforms
(Note - Other rapid diagnostic platforms include coagulation tests, glucose monitoring systems, and other rapid diagnostic platforms)

Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Application

  • Infectious Diseases Testing
  • Pregnancy And Fertility Testing
  • Cardiac Metabolism Testing
  • Cholesterol Testing
  • Tumor/Cancer Markers Testing
  • Blood Glucose Testing
  • Urinalysis
  • Hematology Testing
  • Other Tests
(Note - Other tests include drugs of abuse, fecal occult, and coagulation tests)

Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care/Self-testing
  • Other End Users
(Note - Other end users include ambulatory care centers, nursing homes, and public places (airports, hotels, and workplaces)

Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Geography

  • France
  • India
  • Australia
  • Indonesia
  • Singapore
  • Sri Lanka
  • Madagascar
  • Mauritius
  • Reunion
  • Mayotte
  • Seychelles
  • Comoros

Table of Contents

1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.4. Assumptions for this Study
2.5. Limitations for the Study

3. Executive Summary

4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population
4.2.2. Growing Prevalence of Infectious Diseases
4.2.3. Increasing Need for Rapid Decision-making & Growing Demand for Point-of-Care (POC) Diagnostics
4.2.4. The Outbreak of the COVID-19 Pandemic
4.3. Restraints
4.3.1. Variance in Test Results
4.4. Opportunities
4.4.1. Untapped Potential in Emerging Economies of the Countries in the Indian Ocean Region
4.5. Challenges
4.5.1. Reluctance toward Changing Existing Diagnostic Practices
4.6. Rapid Diagnostics: Innovations & Upcoming Technologies

5. Rapid Diagnostic Kits Market in Indian Ocean Region Countries, by Product
5.1. Introduction
5.2. Professional Kits
5.3. OTC Kits

6. Rapid Diagnostic Kits Market in Indian Ocean Region Countries, by Platform
6.1. Introduction
6.2. Immunoassays
6.3. Molecular Detection Tests
6.4. Other Rapid Diagnostic Platforms

7. Rapid Diagnostic Kits Market for Indian Ocean Region Countries, by Application
7.1. Introduction
7.2. Infectious Diseases Testing
7.3. Pregnancy & Fertility Testing
7.4. Cardiac Metabolism Testing
7.5. Cholesterol Testing
7.6. Tumor/Cancer Markers Testing
7.7. Blood Glucose Testing
7.8. Urinalysis
7.9. Hematology Testing
7.10. Other Tests

8. Rapid Diagnostic Kits Market for Indian Ocean Region Countries, by End User
8.1. Introduction
8.2. Hospital & Clinics
8.3. Diagnostic Laboratories
8.4. Home Care/Self-testing
8.5. Other End Users

9. Rapid Diagnostic Kits Market in Indian Ocean Region Countries, by Geography
9.1. Introduction
9.2. France
9.3. India
9.4. Australia
9.5. Indonesia
9.6. Singapore
9.7. Sri Lanka
9.8. Madagascar
9.9. Mauritius
9.10. Réunion
9.11. Mayotte
9.12. Seychelles
9.13. Comoros

10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)
11.1. Abbott Laboratories (U.S.)
11.2. Becton, Dickinson and Company (BD) (U.S.)
11.3. Bio-Rad Laboratories, Inc. (U.S.)
11.4. F. Hoffmann-La Roche Ltd (Switzerland)
11.5. ACON Laboratories, Inc. (U.S.)
11.6. Danaher Corporation (U.S.)
11.7. Thermo Fisher Scientific Inc. (U.S.)
11.8. bioMérieux S.A. (France)
11.9. Alfa Scientific Designs, Inc. (U.S.)
11.10. BTNX Inc. (Canada)
11.11. Meridian Bioscience, Inc. (U.S.)
11.12. Trinity Biotech plc (Ireland)

12. Appendix
12.1. Questionnaire

Companies Mentioned

  • Abbott Laboratories (U.S.)
  • Becton
  • Dickinson and Company (U.S.)
  • Bio-Rad Laboratories Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • ACON Laboratories Inc. (U.S.)
  • Danaher Corporation (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • bioMérieux S.A. (France)
  • Alfa Scientific Designs Inc. (U.S.)
  • BTNX Inc. (Canada)
  • Meridian Bioscience Inc. (U.S.)
  • Trinity Biotech plc (Ireland).